MedTrace Logo

Biomarker Study of Chemotherapy Resistance and Outcomes in Samples From Older Patients With Acute Myeloid Leukemia

NCT01421875 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 257

Last updated 2017-05-17

No results posted yet for this study

Summary

RATIONALE: Studying blood samples from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.

PURPOSE: This research trial studies biomarkers related to chemotherapy resistance and outcomes in samples from older patients with acute myeloid leukemia.

Conditions

Interventions

GENETIC

DNA methylation analysis

GENETIC

RNA analysis

GENETIC

gene expression analysis

GENETIC

microarray analysis

GENETIC

nucleic acid sequencing

OTHER

laboratory biomarker analysis

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Eastern Cooperative Oncology Group

    lead NETWORK

Principal Investigators

  • Ross Levine, MD · Memorial Sloan Kettering Cancer Center

Eligibility

Min Age
61 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-17
Primary Completion
2011-10-17
Completion
2011-10-17

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01421875 on ClinicalTrials.gov